TABLE 4.
Changes of serum IL‐10, IL‐1β, IL‐6, MCP‐1, TNF‐α, IP‐10 and IL‐4 in COVID‐19 patients
| Median (IQR) (pg/mL) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Course | n | IL‐10 | IL‐1β | IL‐6 | MCP‐1 | TNF‐α | IP‐10 | IL‐4 |
| a | 3 | 3.15 | 8.77 | 6.17 | 49.69 | 4.77 | 120.66 | 31.30 |
| b | 7 | 7.60 (8.49) | 6.99 (4.89) | 7.95 (6.13) | 66.39 (82.28) | 22.18 (7.15)# | 32.62 (43.16) | 52.59 (32.80) |
| c | 31 | 5.53 (5.50) | 8.99 (3.70) | 8.85 (7.58) | 59.34 (96.05) | 19.48 (20.00)# | 30.60 (55.69) | 54.55 (24.74)# |
| d | 26 | 4.60 (5.21)* | 8.28 (6.83) | 7.42 (6.80) | 49.23 (41.98) | 18.57 (20.18) | 34.99 (24.99)# | 46.52 (41.95) |
| e | 3 | 2.64 | 9.94 | 8.62 | 52.04 | 16.28 | 28.12 | 55.39 |
| P | / | P > .05 | ||||||
a. 0‐14 days, b. 15‐28 days, c. 29‐42 days, d. 43‐56 days and e. 57‐70 days, #means compare with a, P < .05; *means compare with c, P < .05.